Small Molecules

Is the industry ready for continuous manufacturing?

Cures for all presents a real focus for the next decade – but companies must be rewarded for their work.

How will the adoption of novel approaches to the development of excipients help overcome the challenges of poorly soluble APIs?

After a vibrant year of advances in pharmaceutical development and manufacturing technologies, we present The Medicine Maker 2019 Innovation Awards.

Hovione’s New Jersey-based site has provided process development and small volume API manufacturing since 2002.

The reported benefits of continuous manufacturing for small molecules over batch manufacturing include accelerated product and process development.

The economic and technological advantages of continuous flow chemistry are driving adoption by API manufacturers.

Small molecules continue to play a significant role in the development of innovative treatments.

How can wood be used to produce pharmaceutically relevant compounds?

Continuus was established with the primary objective of shining a spotlight on continuous manufacturing.